Tumanggong, Mulok H.
HRN: 16 41 70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/19/2022
12/26/2022
INTRAVENOUS
500 Mg
Q8h
Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes